The association between microvascular and macrovascular diseases and diabetes remission after bariatric surgery
Surgical Endoscopy, 2024•Springer
Background Type-2 diabetes mellitus (T2DM) results in detrimental vascular complications
including both microvascular and macrovascular diseases. Roux-en-Y gastric bypass
(RYGB) and sleeve gastrectomy (SG) are effective weight-loss therapies that enhance T2DM
remission. However, limited data are present regarding the association between diabetes-
associated diseases before RYGB and SG with T2DM remission. Methods This is a
retrospective cohort study in patients with T2DM who underwent RYGB or SG. We collected …
including both microvascular and macrovascular diseases. Roux-en-Y gastric bypass
(RYGB) and sleeve gastrectomy (SG) are effective weight-loss therapies that enhance T2DM
remission. However, limited data are present regarding the association between diabetes-
associated diseases before RYGB and SG with T2DM remission. Methods This is a
retrospective cohort study in patients with T2DM who underwent RYGB or SG. We collected …
Background
Type-2 diabetes mellitus (T2DM) results in detrimental vascular complications including both microvascular and macrovascular diseases. Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) are effective weight-loss therapies that enhance T2DM remission. However, limited data are present regarding the association between diabetes-associated diseases before RYGB and SG with T2DM remission.
Methods
This is a retrospective cohort study in patients with T2DM who underwent RYGB or SG. We collected data on preoperative microvascular (i.e., retinopathy, nephropathy, and neuropathy) and macrovascular (coronary artery disease, cerebrovascular accidents, and peripheral artery disease) diabetes-associated diseases. Our end points included assessment of association and cumulative effect of diabetes-associated diseases and disease remission. We also performed a multivariate logistic regression to evaluate the parameters associated with T2DM remission.
Results
A total of 536 patients (67% female, 94% White) were included in this study. Patients without diabetes-associated diseases had an OR of 2.72 (95% CI 1.92 to 3.88) to achieve T2DM remission compared to patients with diabetes-associated diseases (27.9% vs 59.4%; p < 0.001). Importantly, there was an additive effect of the number of diabetes-associated diseases on the T2DM remission (p < 0.001). We demonstrate a significant association between HbA1c (p < 0.001), number of diabetes medications (p < 0.001), T2DM duration (p < 0.001), surgery type (p = 0.009), and insulin use (p = 0.04) with T2DM remission.
Conclusion
Patients with presurgical diabetes-associated diseases had a lower remission rate after RYGB and SG. Not only do these complications represent a more practical and consistent variable to predict T2DM remission, but also help planning a multidisciplinary management of patients with more severe T2DM.
Springer
以上显示的是最相近的搜索结果。 查看全部搜索结果